Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001013594-25-001066
Filing Date
2025-08-14
Accepted
2025-08-14 21:38:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 5309
2 exh1.htm EX-1 5766
  Complete submission text file 0001013594-25-001066.txt   13157
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Subject) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-45947 | Film No.: 251222225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 EXCHANGE PLACE JERSEY CITY NJ 07302
Business Address 15 EXCHANGE PLACE JERSEY CITY NJ 07302 212-956-2221
PAULSON & CO. INC. (Filed by) CIK: 0001035674 (see all company filings)

EIN.: 133796759 | State of Incorp.: DE | Fiscal Year End: 1231